Searched for
R M ANJANA
Obesity, diabetes, heart disease: 62% of Indians’ daily calories come from just 2 foods; Experts suggest healthier regional alternativesA new study reveals Indians consume nearly 62% of daily calories from carbohydrates. This carb-heavy diet, dominated by white rice and refi...- Type 2 diabetes triggering heart attacks in the 30s: Why India’s youth are at risk?Type 2 diabetes is increasingly affecting young Indians, accelerating heart disease risks due to factors like genetics, visceral fat, and u...
- India’s diabetes tsunami: Why it’s striking earlier and harderIndia faces a rapidly escalating diabetes crisis, with cases emerging in younger individuals and complications developing swiftly. Lifestyl...
- Addressing “Metabolic Syndrome”: Key to tackling type-2 diabetes in IndiaIndia is facing an alarming rise in metabolic syndrome, which is associated with Type-2 diabetes and other severe health issues. Factors li...
- From 'Guruvayoor Ambala Nadayil' to 'Satyabhama': Watch new Malayalam movies on OTT platforms like Netflix, Disney+ Hotstar, Prime VideoDiscover the latest additions to your streaming lineup with this week's new OTT releases. From the comedy-drama 'Guruvayoor Ambala Nadayil'...
- The banyan tree of health: Combating the titan twindemic of diabetes and obesityThe twindemic of type 2 diabetes and obesity is a major challenge in India, with over 100 million adults living with diabetes and roughly 2...
- Buy Ajanta Pharma, target price Rs 1580: ICICI SecuritiesAjanta Pharma, incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 18277.05 Crore) operating in Pharmaceuticals ...
- Over 11% Indians diabetic, 36% have hypertension: Lancet survey showsA nationwide survey published in The Lancet Diabetes & Endocrinology journal has found that 11.4% of Indians have diabetes, rising from 7.5...
- Buy Ajanta Pharma, target price Rs 1410: Motilal Oswal Financial ServicesAjanta Pharma, incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 15546.07 Crore) operating in Pharmaceuticals ...
- Including almonds in your daily diet may lower risk of diabetes: StudyEating almonds regularly may help control blood sugar.
- Buy Ajanta Pharma, target Rs 1065: Jayesh BhanushaliBuy Ajanta Pharma Ltd. at a price target of Rs 1065.0 and a stoploss at Rs 988 from entry point.
- Sell Ajanta Pharma, target Rs 935: Shubham AggarwalSell Ajanta Pharma Ltd. at a price target of Rs 935.0 and a stoploss at Rs 1015 from entry point.
- Buy Ajanta Pharma, target Rs 950: Dr CK NarayanBuy Ajanta Pharma Ltd. at a price target of Rs 950.0 and a stoploss at Rs 922 from entry point.
- Sell Ajanta Pharma, target Rs 1040: Dr CK NarayanSell Ajanta Pharma Ltd. at a price target of Rs 1040.0 and a stoploss at Rs 1065 from entry point.
- Buy Ajanta Pharma, target Rs 1225: Manas JaiswalBuy Ajanta Pharma Ltd. at a price target of Rs 1225.0 and a stoploss at Rs 1140 from entry point.
- Sell Ajanta Pharma, target Rs 1075: Kunal BothraSell Ajanta Pharma Ltd. at a price target of Rs 1075.0 and a stoploss at Rs 1125 from entry point.
- Buy Ajanta Pharma, target Rs 1250: Manas JaiswalBuy Ajanta Pharma Ltd. at a price target of Rs 1250.0 and a stoploss at Rs 1160 from entry point.
- Buy Ajanta Pharma, target Rs 1045: Dr CK NarayanBuy Ajanta Pharma Ltd. at a price target of Rs 1045 and a stoploss at Rs 1015 from entry point.
- President Ram Nath Kovind confers Sangeet Natak Akademi awards, fellowshipsKovind also presented Sangeet Natak Akademi Awards to 43 eminent artists in five categories for the year 2016.
- Sell Ajanta Pharma, target Rs 1500: Rakesh BansalSell Ajanta Pharma Ltd. at a price target of Rs 1500.0 and a stop loss at Rs 1750.0 from entry point
Load More
